Drug Diversion Prevention in Healthcare


Book Description

Drug Diversion Prevention in Healthcare Kimberly New, BSN, JD Theft of controlled substances at hospitals has always been a problem of paramount importance, but even with increased security measures, it still occurs. Drug Diversion Prevention in Healthcare discusses the issue of drug diversion in detail and demonstrates the components of a solid prevention plan. Loaded with tools and checklists, this book is designed to help hospital security officials create awareness of the drug diversion problem. You will learn how to design a program to keep staff accountable for drug administrations, as well as audits that monitor drug distribution from delivery to patient administration. This resource will help you: Establish an effective drug diversion prevention plan among hospital staff Understand the fundamental issues of drug diversion Create awareness among staff using tools and checklists Learn to recognize suspected diverters and mitigate problem areas in your hospital Effectively confront and deal with diverters in your facility




Medications for Opioid Use Disorder Save Lives


Book Description

The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.




Pain Management and the Opioid Epidemic


Book Description

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.




Countering the Problem of Falsified and Substandard Drugs


Book Description

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.




The ADA Practical Guide to Substance Use Disorders and Safe Prescribing


Book Description

Dentists have been inundated by patients with an array of complicated medical conditions and pain/sedation management issues. This is in addition to a variety of legal regulations dentists must follow regarding the storage and recordkeeping of controlled substances. Avoid unknowingly putting your practice at risk by becoming victim to a scam or violating a recordkeeping requirement with The ADA Practical Guide to Substance Use Disorders and Safe Prescribing. This Practical Guide is ideal for dentists and staff as they navigate: • Detecting and deterring substance use disorders (SUD) and drug diversion in the dental office (drug-seeking patients) • Prescribing complexities • Treating patients with SUD and complex analgesic and sedation (pain/sedation management) needs and the best use of sedation anxiety medication • Interviewing and counselling options for SUD • Federal drug regulations Commonly used illicit, prescription, and over-the-counter drugs, as well as alcohol and tobacco, are also covered. Special features include: • Clinical tools proven to aid in the identification, interviewing, intervention, referral and treatment of SUD • Basic elements of SUD, acute pain/sedation management, and drug diversion • Summary of evidence-based literature that supports what, when and how to prescribe controlled substances to patients with SUD • Discussion of key federal controlled substance regulations that frequently impact dental practitioners • Checklists to help prevent drug diversion in dental practices • Chapter on impaired dental professionals • Case studies that examine safe prescribing and due diligence







Police Drug Diversion


Book Description

"In 2006, the Australian Institute of Criminology assessed the effectiveness of state and territory drug diverson programs established by the Illicit Drug Diversion Initiative (IDDI) to reduce illicit drug users' contact with the criminal justice system. This report examines programs run by policing agencies. It looks at the structure and effectiveness of Australian state and territroy approaches to IDDI programs through comparison of offending behaviour before and after program attendance. The type and number of prior offences, Indigenous status, age, gender and compliance with intervention programs were examined as potential predictors of post-diversion levels of recidivism. While varying in significance between jurisdictions, these issues show their influence in affecting offender numbers, offending frequency, offence type and associated factors."--Backcover.




United States Attorneys' Manual


Book Description




Diversion


Book Description

There's good guys, bad guys, and then there's Lucky. Former drug trafficker Richmond "Lucky" Lucklighter flaunts his past like a badge of honor.He speaks his mind, doesn't play nice, and flirts with disaster while working off his sentence with the Southeastern Narcotics Bureau. If he can keep out of trouble a while longer he'll be a free man-after he trains his replacement.Textbook-quoting, by the book Bo Schollenberger is everything Lucky isn't. Lucky slurps coffee, Bo lives caffeine free. Lucky worships bacon, Bo eats tofu. Lucky trusts no one, Bo calls suspects by first name. Yet when the chips are down on their shared case of breaking up a drug diversion ring, they may have more in common than they believe.Two men. Close quarters. Friction results in heat. But Lucky scoffs at partnerships, no matter how thrilling the roller-coaster. Bo has two months to break down Lucky's defenses... and seconds are ticking by.




Dangerous Doses


Book Description

An exploration of drug counterfeiting activities in America traces a drug theft investigation in Florida with ties to a national network of drug polluters and the government, exposing how political interests may be compromising the integrity of the nation's medical distribution system. Reprint. 30,000 first printing.